The Daily Papule

Monday 12 October

EJD
Compound glycyrrhizin plus intravenous immunoglobulin for regorafenib‑induced severe Stevens-Johnson syndrome in a patient with advanced hepatocellular carcinoma.
Liu Y, Li J, Ran LEuropean Journal of Dermatology
No abstractRead at publisher(opens in a new tab)

Saturday 10 October

Derm Pract ConceptObservational studyLetter
Factors Influencing the Treatment Response of Tetracyclines for Papulopustular Rash Induced by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Retrospective Study.
Kim TM, Kim N, … senior author Jo SJDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)
Derm Pract ConceptReview
Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors
A Clinical Review of Reaction Patterns.
Park I, Bayrouti A, … senior author Nguyen KBDermatology Practical & Conceptual
Read at publisher(opens in a new tab)
Derm Pract ConceptLetter
Palmoplantar Pustulosis Induced by Intravenous Anifrolumab
An Emerging Dermatologic Adverse Event?
Zanghì S, Bighetti S, … senior author Maione VDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)

Friday 9 October

Pediatr Derm
Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States.
Razi S, Agarwal P, … senior author Rao BKPediatric Dermatology
Read at publisher(opens in a new tab)
J Dermatol
Clinical Study of Bullous Pemphigoid With Oral Mucosal Symptoms After Oral Administration of Dipeptidyl Peptidase-4 Inhibitors.
Akira Y, Minabe M, … senior author Kouno MJournal of Dermatology
Read at publisher(opens in a new tab)

Thursday 8 October

JAADObservational study
Severe Cutaneous Adverse Reactions With Overlapping Features
A Retrospective Study From Two Tertiary Centers.
Caputo V, Guida S, … senior author Rongioletti FJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
JAAD
Bispecific antibody-associated desquamative palmoplantar dermatitis
a distinct palmoplantar toxicity beyond HFS and HFSR.
Nikolaou V, Sibaud VJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Wednesday 7 October

JAAD
Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis.
Li W, Xu X, … senior author Yang JJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)
Derm Ther
Topical Delgocitinib for Capecitabine-Induced Hand-Foot Syndrome: A Therapeutic Option?
Rapparini L, Martelli G, … senior author Starace MDermatology and Therapy
Read at publisher(opens in a new tab)

Monday 5 October

JAAD
Drug-Induced Subacute Cutaneous Lupus Erythematosus
Treatment and Outcome Data.
Orofino J, Whittelsey M, … senior author LaChance AHJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Sunday 4 October

Contact DermObservational study
Patch Test Relevance and Systemic Exposure Pathways in Eczema Patterns Suspected of Systemic Contact Dermatitis.
Garg V, Bishnoi A, … senior author Handa SContact Dermatitis
Read at publisher(opens in a new tab)

Saturday 3 October

Arch Derm Res
An educational intervention on the cutaneous toxicities of cancer treatment among patients with gastrointestinal cancers
Williams MCG, Huggins LKL, … senior author Leventhal JArchives of Dermatological Research
No abstractRead at publisher(opens in a new tab)

Thursday 1 October

JAADClinical trial
Early use of mepolizumab in DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome
A prospective multicenter, open-label, pilot study.
Yun J, Richardson R, … senior author Carr AJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Wednesday 30 September

Clin Exp DermObservational study
Autoimmune Bullous Disorders Associated With Immune Checkpoint Inhibitors
A Retrospective Review of a Single Center Cohort Over the Past Decade.
Cull D, Holder K, … senior author Sominidi Damodaran SClinical and Experimental Dermatology
Read at publisher(opens in a new tab)
Skin Health DisCase report
Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists.
Carson L, Eisner M, … senior author Weatherhead SSkin Health and Disease
Read at publisher(opens in a new tab)

Tuesday 29 September

Derm TherReview
Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review.
Chung CS, Kherallah K, … senior author Lee KHDermatology and Therapy
Read at publisher(opens in a new tab)
JCMS
Sorafenib-Induced Hand Foot Reaction.
Antakanavar GM, Daljit TJournal of Cutaneous Medicine and Surgery
No abstractRead at publisher(opens in a new tab)

Monday 28 September

J Cutan PatholCase report
Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B-Cell Lymphoma.
Jaguan D, Nguyen C, Choi JNJournal of Cutaneous Pathology
Read at publisher(opens in a new tab)
Dermatitis
Diagnostic Performance of the Lymphocyte Transformation Test and Patch Testing in Delayed Hypersensitivity Drug Reactions.
Koumaki D, Gregoriou S, … senior author Krasagakis KDermatitis
Read at publisher(opens in a new tab)

Journals and topics

Drug reactions

Monday 12 October

Compound glycyrrhizin plus intravenous immunoglobulin for regorafenib‑induced severe Stevens-Johnson syndrome in a patient with advanced hepatocellular carcinoma.

Saturday 10 October

Factors Influencing the Treatment Response of Tetracyclines for Papulopustular Rash Induced by Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Retrospective Study.

Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors

Palmoplantar Pustulosis Induced by Intravenous Anifrolumab

Friday 9 October

Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States.

Clinical Study of Bullous Pemphigoid With Oral Mucosal Symptoms After Oral Administration of Dipeptidyl Peptidase-4 Inhibitors.

Thursday 8 October

Severe Cutaneous Adverse Reactions With Overlapping Features

Bispecific antibody-associated desquamative palmoplantar dermatitis

Wednesday 7 October

Necrotic eruptions indicate severe myositis in immune checkpoint inhibitor-associated dermatomyositis.

Topical Delgocitinib for Capecitabine-Induced Hand-Foot Syndrome: A Therapeutic Option?

Monday 5 October

Drug-Induced Subacute Cutaneous Lupus Erythematosus

Sunday 4 October

Patch Test Relevance and Systemic Exposure Pathways in Eczema Patterns Suspected of Systemic Contact Dermatitis.

Saturday 3 October

An educational intervention on the cutaneous toxicities of cancer treatment among patients with gastrointestinal cancers

Thursday 1 October

Early use of mepolizumab in DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome

Wednesday 30 September

Autoimmune Bullous Disorders Associated With Immune Checkpoint Inhibitors

Novel cutaneous adverse effects of the increasingly prevalent glucagon-like peptide 1 agonists.

Tuesday 29 September

Management Considerations for Patients with Hidradenitis Suppurativa and Lupus Spectrum Disease: A Narrative Review.

Sorafenib-Induced Hand Foot Reaction.

Monday 28 September

Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B-Cell Lymphoma.

Diagnostic Performance of the Lymphocyte Transformation Test and Patch Testing in Delayed Hypersensitivity Drug Reactions.